These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
665 related articles for article (PubMed ID: 9726240)
21. The decrease in phosphatidylinositol 4,5-bisphosphate in ADP-stimulated washed rabbit platelets is not primarily due to phospholipase C activation. Vickers JD; Kinlough-Rathbone RL; Mustard JF Biochem J; 1986 Jul; 237(2):327-32. PubMed ID: 3026316 [TBL] [Abstract][Full Text] [Related]
22. AMP-Activated Protein Kinase Mediates the Antiplatelet Effects of the Thiazolidinediones Rosiglitazone and Pioglitazone. Liu Y; Park JM; Chang KH; Huh HJ; Lee K; Lee MY Mol Pharmacol; 2016 Feb; 89(2):313-21. PubMed ID: 26643379 [TBL] [Abstract][Full Text] [Related]
23. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets. Fälker K; Lange D; Presek P Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804 [TBL] [Abstract][Full Text] [Related]
24. Functional implications of tyrosine protein phosphorylation in platelets. Simultaneous studies with different agonists and inhibitors. Bachelot C; Cano E; Grelac F; Saleun S; Druker BJ; Levy-Toledano S; Fischer S; Rendu F Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):923-8. PubMed ID: 1622407 [TBL] [Abstract][Full Text] [Related]
25. Thrombin-induced abnormal platelet activation in spontaneously hypertensive rats is linked with phosphoinositides turnover and phosphorylation of 47,000 and 20,000 dalton proteins. Huzoor-Akbar ; Anwer K Thromb Res; 1988 Jan; 49(1):5-21. PubMed ID: 2831638 [TBL] [Abstract][Full Text] [Related]
26. Thrombin-stimulated phosphatidylinositol 3-kinase activity in platelets is associated with activation of PYK2 tyrosine kinase: activation of both enzymes is aggregation independent. Sayed MR; Sheid MP; Stevens CM; Duronio V J Cell Physiol; 2000 Jun; 183(3):314-20. PubMed ID: 10797305 [TBL] [Abstract][Full Text] [Related]
27. Phosphoinositide breakdown as an indirect link between stimulation and aggregation of rat platelets by thrombin and collagen. Kito M; Narita H; Ishinaga M; Park HJ; Takamura H J Biochem; 1985 Mar; 97(3):765-72. PubMed ID: 2991207 [TBL] [Abstract][Full Text] [Related]
28. alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Freedman JE; Farhat JH; Loscalzo J; Keaney JF Circulation; 1996 Nov; 94(10):2434-40. PubMed ID: 8921785 [TBL] [Abstract][Full Text] [Related]
29. U73122 affects the equilibria between the phosphoinositides as well as phospholipase C activity in unstimulated and thrombin-stimulated human and rabbit platelets. Vickers JD J Pharmacol Exp Ther; 1993 Sep; 266(3):1156-63. PubMed ID: 8396627 [TBL] [Abstract][Full Text] [Related]
30. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo. Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801 [TBL] [Abstract][Full Text] [Related]
31. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action. Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791 [TBL] [Abstract][Full Text] [Related]
32. Troglitazone, a new antidiabetic agent possessing radical scavenging ability, improved decreased skin blood flow in diabetic rats. Fujiwara T; Ohsawa T; Takahashi S; Ikeda K; Okuno A; Ushiyama S; Matsuda K; Horikoshi H Life Sci; 1998; 63(22):2039-47. PubMed ID: 9839548 [TBL] [Abstract][Full Text] [Related]
33. Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes. Bähr M; Spelleken M; Bock M; von Holtey M; Kiehn R; Eckel J Diabetologia; 1996 Jul; 39(7):766-74. PubMed ID: 8817100 [TBL] [Abstract][Full Text] [Related]
34. Neomycin inhibits agonist-stimulated polyphosphoinositide metabolism and responses in human platelets. Tysnes OB; Verhoeven AJ; Holmsen H Biochem Biophys Res Commun; 1987 Apr; 144(1):454-62. PubMed ID: 3034251 [TBL] [Abstract][Full Text] [Related]
35. Effects of chlorpromazine on phosphatidylinositol turnover following thrombin stimulation of human platelets. Wakatabe H; Tsukahara T; Ishigooka J; Miura S Biol Psychiatry; 1991 May; 29(10):965-78. PubMed ID: 1905965 [TBL] [Abstract][Full Text] [Related]
36. PDGF modifies phosphoinositide metabolism and inhibits aggregation and release in human platelets. Bryckaert MC; Rendu F; Tobelem G; Caen J Biochem Biophys Res Commun; 1986 Feb; 135(1):52-7. PubMed ID: 3006686 [TBL] [Abstract][Full Text] [Related]
37. Erbstatin blocks platelet activating factor-induced protein-tyrosine phosphorylation, polyphosphoinositide hydrolysis, protein kinase C activation, serotonin secretion and aggregation of rabbit platelets. Salari H; Duronio V; Howard SL; Demos M; Jones K; Reany A; Hudson AT; Pelech SL FEBS Lett; 1990 Apr; 263(1):104-8. PubMed ID: 1691984 [TBL] [Abstract][Full Text] [Related]
38. The in vitro effect of eptifibatide, a glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets. Ciborowski M; Tomasiak M Acta Pol Pharm; 2009; 66(3):235-42. PubMed ID: 19645323 [TBL] [Abstract][Full Text] [Related]
39. Pyridoxine increases nitric oxide biosynthesis in human platelets. Wu Y; Liu Y; Han Y; Cui B; Mi Q; Huang Y; Wang L; Jiang Q; Chen Q; Liu N; Ferro A; Ji Y Int J Vitam Nutr Res; 2009 Mar; 79(2):95-103. PubMed ID: 20108211 [TBL] [Abstract][Full Text] [Related]
40. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP. Shen MY; Hsiao G; Liu CL; Fong TH; Lin KH; Chou DS; Sheu JR Br J Haematol; 2007 Nov; 139(3):475-85. PubMed ID: 17868048 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]